Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: Double-blind, randomized, controlled clinical trial

Michael Simons, Brian H. Annex, Roger J. Laham, Neal Kleiman, Timothy Henry, Harold Dauerman, James E. Udelson, Ernesto V. Gervino, Marilyn Pike, M. J. Whitehouse, Thomas Moon, Nicolas A. Chronos

Research output: Contribution to journalArticlepeer-review

602 Scopus citations

Fingerprint

Dive into the research topics of 'Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: Double-blind, randomized, controlled clinical trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Agricultural and Biological Sciences